CNS Pharmaceuticals, Inc. Increase (Decrease) Due from Other Related Parties
CNS Pharmaceuticals, Inc. (CNSP) reported Increase (Decrease) Due from Other Related Parties of $0 for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-08-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseDueFromOtherRelatedParties · last filed 2022-08-12
- CNS Pharmaceuticals, Inc. increase (decrease) due from other related parties for the quarter ending 2022-06-30 was $0.00.
- CNS Pharmaceuticals, Inc. increase (decrease) due from other related parties for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- CNS Pharmaceuticals, Inc. increase (decrease) due from other related parties for the quarter ending 2021-06-30 was $0.00.
- CNS Pharmaceuticals, Inc. increase (decrease) due from other related parties for the quarter ending 2021-03-31 was $132.65K.
| Period end | Increase (Decrease) Due from Other Related Parties 3 month | Increase (Decrease) Due from Other Related Parties 6 month |
|---|---|---|
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $0.00 10-Q · filed 2022-08-12 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-13 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $132.65K 10-Q · filed 2022-08-12 |
| 2021-03-31 | $132.65K 10-Q · filed 2022-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |